Skip to content

Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)

Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02553967
Acronym
REMASCO
Enrollment
49
Registered
2015-09-18
Start date
2016-01-07
Completion date
2021-04-15
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

functional Magnetic Resonance Imaging (fMRI), Breast reconstructive surgery, Breast Q questionnaire

Brief summary

Breast reconstruction is an integral part of the management of patients with breast cancer and treated by total mastectomy. The aim of breast reconstruction is to get a satisfying aesthetic and functional result (sensitivity) and that would enable the patient to appropriate the reconstructed breast. Patient satisfaction assessed subjectively by questionnaires would be better in autologous reconstructions than in reconstructions by prosthesis. The aim of our trial is to use functional MRI (fMRI) as an objective evaluation tool to describe the brain functional changes of sensory projections after immediate or secondary breast reconstruction.

Detailed description

Patients responding criteria for selection and not objecting to participate in this trial will address a quality of life questionnaire at baseline. Then the study procedures differ depending on which group the patient belongs to. Immediate breast reconstruction group : Six months after surgery (or six months after the implantation of the definitive prosthesis in case of use of a tissue expander), a postoperative fMRI will be performed and patients will be asked to complete a quality of life form and a satisfaction form. Secondary breast reconstruction group : * In the two months preceding the surgery, a preoperative fMRI will be performed. * Six months after surgery (or six months after the implantation of the definitive prosthesis in case of use of a tissue expander), a postoperative fMRI will be performed and patients will be asked to complete a quality of life form and a satisfaction form.

Interventions

DEVICEFunctional MRI

Functional MRI

Sponsors

Centre Oscar Lambret
Lead SponsorOTHER
University Hospital, Lille
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient with an indication of unilateral total mastectomy with immediate breast reconstruction for initial breast cancer or recurrence, Or patient undergoing a unilateral secondary breast reconstruction 2. WHO performance status less than or equal to 2 3. Age ≥ 18 years 4. For patients of childbearing age, use of an effective contraceptive method for the duration of the study 5. Patient having been informed and having signed an informed consent form for the study.

Exclusion criteria

1. Patient undergoing a breast reconstruction by exclusive lipomodelling 2. Contraindication to MRI : claustrophobia, intra-orbital metallic fragment, pregnancy, cochlear implants, incompatible metallic foreign body such as certain pacemaker and mechanical valves 3. Patient with an indication of preoperative radiotherapy or adjuvant chemotherapy according to regional and/or national standards 4. History of brain surgery 5. History of contralateral breast surgery 6. History of prophylactic total mastectomy 7. Reconstruction techniques using a mixed procedure (autologous + prosthesis) 8. Patient on medication that may alter the BOLD signal in MRI 9. Pregnant or breastfeeding women 10. Patient under tutorship or guardianship

Design outcomes

Primary

MeasureTime frame
BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the reconstructed breast and the non-operated breast.6 months

Secondary

MeasureTime frame
BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the breast reconstructed using an autologous flap and a prosthesis.6 months
BOLD signal change (difference in intensity and anatomic location) in the regions activated during breast palpation between the reconstructed breast and the mastectomy scar before reconstruction.6 months
Topography variation in brain sensory projection area after total mastectomy and breast reconstruction.6 months
Satisfaction score and pre and postoperative quality-of-life score (Breast Q) according to a Likert scale.6 months

Countries

France

Contacts

PRINCIPAL_INVESTIGATORClaudia REGIS, MD

Centre Oscar Lambret

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026